06:30 LRN Newscast October 6

So how much money is Louisiana getting from the recent funding bill approved by Congress that contains hurricane recovery dollars? Kevin Gallagher has more…
cut 1 (33) “….I’m Kevin Gallagher”

The number of COVID patients in the hospital has fallen below 700 statewide, which is the lowest total since July 18th when the fourth surge was just starting to ramp up. The Louisiana Department of Health reports 82-percent of hospitalized patients are unvaccinated.

Drugmaker AstraZeneca, has asked the Food and Drug Administration to authorize emergency use of what’s been called a first-of-a-kind antibody treatment to prevent COVID-19. The drug would be for individuals with compromised immune systems and need more protection to go along with the vaccine…
cut 12 (10) “…SARS-cov-2″
That’s Assistant Dean for Translational Science at LSU Health New Orleans, Doctor Lucio Miele, says late-stage human trials show that AstraZeneca’s antibody drug reduced the risk of developing COVID symptoms by 77-percent.

A medical center in Louisiana is leading the nation in using innovative robotic technology to diagnose lung cancer. Baton Rouge General pulmonologist Dr. Michael Sanchez says the new Monarch Platform can mean earlier, more accurate detection of lung cancers or pre-cancerous nodules. He says manual bronchoscopes can only be guided so far into the body…:
Cut 13 (11) “…without it.”
Use of Monarch was recently approved by the U.S. Food & Drug Administration